Oral 31: Idiosyncratic Drug-Induced Liver Injury (DILI) in the United States: A Report of 1,257 Prospectively Enrolled Patients Author Insight…
Inside the Inaugural Men’s Health Conference: ACG Leaders Bring the Case for Prevention to Congress
ACG was proud to participate in the Congressional Men’s Health Caucus conference
As Congress Eyes Medicare Reform, ACG Is Representing the Clinical GI Perspective
After years of incremental fixes and stopgap solutions on Medicare reimbursement, Congress is finally taking a closer look
Proposed NIH Cuts Would Hurt GI Research – Here’s How ACG Is Fighting Back
ACG is alarmed by CMS’ proposal for new ‘efficiency’ cuts and changes to practice expense methodology
ACG Advocacy Day 2026: Advocacy Takes Guts – Advancing Digestive Health
ACG leaders advance GI’s public policy priorities in Congress, including utilization management reform and colorectal cancer screening
Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease
Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A.…
SVR12 of 99% Achieved With a Ribavirin-Free Regiment of ABT-450r Ombitasvir and Dasabuvir in HCV Genotype 1b-Infected Patients
Oral 4: SVR12 (sustained virologic response 12 weeks post-treatment) of 99% Achieved With a Ribavirin-Free Regiment Author Insight from Andreas…
Association of Mean Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5 Year Prospective Study
Oral 61 Association of Mean Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5 Year Prospective Study…
Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients With Chronic Hepatitis C (CH-C) Treated With an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir (SOF)
Plenary Session 2: Liver Tuesday, October 21 8:30 am – 10:00 am MODERATORS: Kris V. Kowdley, MD, FACG Paul Y.…
Regional Variation of Care for Irritable Bowel Syndrome in the United States
P1719 Regional Variation of Care for Irritable Bowel Syndrome in the United States Author insight from Brian E. Lacy, MD,…
Colorectal Cancer Patients Have Higher Rates of Advanced Features in Their Diminutive Adenomas Compared to Patients Undergoing Average-Risk Screening
Plenary Session 2: Stomach/Colon Wednesday, October 22 8:30 am – 10:15 am Moderators: Joseph C. Anderson, MD Francisco C. Ramirez,…
Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person
P1296 Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person Author insight from Jagpal S. Klair,…
Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT-450/R/Ombitasvir, Dasabuvir and Ribavirin
PRESIDENT’S PLENARY SESSION 1 Monday, October 20 8:00 am – 9:00 am (Terrace Ballroom) Moderators: Harry E. Sarles, Jr., MD,…
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease
P454 Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease Author insight from Monika…